Recombinant IL13 (Tralokinumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all IL13 (Tralokinumab Biosimilar) products
- IL13 (Tralokinumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL13 (Tralokinumab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Tralokinumab Biosimilar - Anti-IL13 mAb
- Characteristics
- Antibody Type: IgG4-lambda
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG4 lambda
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- IL13 (Tralokinumab Biosimilar)
- Abstract
- IL13 (Tralokinumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
CAT-354
Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases. - CAS-No
- 1044515-88-9
-
You are here:
